PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 19, 2005 Subscribe to this News Feed    
 

Sweet Rite for the Diabetic, the Weight-Watcher and the Health-Conscious

Sweet Rite all natural sugar substitute, Clinical Tested. SweetRite passed the Clinical Protocols for Low Glycemic foods as required by FDA and FTC guideline, and as specified by StandardizedClinical Testing Protocols accepted in the United States and worldwide.

(PRWEB) August 19, 2005 -- SweetRite passed the Clinical Protocols for Low Glycemic foods as required by FDA and FTC guideline, and as specified by Standardized Clinical Testing Protocols accepted in the United States and worldwide.

Sweet Rite has been certified to use both the seals of the Low Glycemic Seals.

Nature's Natural Liquid Sweetener the good sense sweetener that will not over stimulate the production of Insulin in the body. Insulin increases fat cell proliferation.

Clinical Test Results, (Glycemic Research Institute) Sweet Rite's TM, Blue Agave Nectar. LOW GLYCEMIC-Glycemic Index 27.0 on the glucose scale. LOW GLYCEMIC LOAD-Glycemic Load 1.6. Sweet RiteTM, passed the Clinical Protocols for "Low Glycemic" foods as required by FDA and FTC guidelines, and as specified by Standardized Clinical Testing Protocols accepted in the United States and worldwide.

Press Release
Contact F.A. Catalano
email sweetrite@comcast.net
web www.sweetrite.com
Ph. 800-558-5009

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Fred Catalano
SWEET RITE
8005585009
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.